Cargando…
Selection of Filovirus Isolates for Vaccine Development Programs
The continuing outbreaks of ebola virus disease highlight the ongoing threat posed by filoviruses. Fortunately, licensed vaccines and therapeutics are now available for Zaire ebolavirus. However, effective medical countermeasures, such as vaccines for other filoviruses such as Sudan ebolavirus and t...
Autores principales: | Wolfe, Daniel N., Sabourin, Carol L., Merchlinsky, Michael J., Florence, William C., Wolfraim, Larry A., Taylor, Kimberly L., Ward, Lucy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471873/ https://www.ncbi.nlm.nih.gov/pubmed/34579282 http://dx.doi.org/10.3390/vaccines9091045 |
Ejemplares similares
-
Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates
por: Niemuth, Nancy A., et al.
Publicado: (2022) -
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development
por: Taylor, Kimberly L., et al.
Publicado: (2022) -
Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names
por: Kuhn, Jens H., et al.
Publicado: (2014) -
Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay
por: Anderson, Michael S., et al.
Publicado: (2020) -
Filovirus Entry
por: Simmons, Graham
Publicado: (2013)